Analytik Jena’s shares in AJ Roboscreen GmbH, acquired in 2005, have now been sold as part of a
management buy out. This comes as part of the Analytik Jena Group’s increased focus on its core activities.
We now are continuing as ROBOSCREEN GmbH, specialized in the development and production of in-vitro diagnostics (IvD) for molecular biology and immunology. Our spin-off will allow us to focus on the increasing demands of the IvD market, while also expanding our own specialized distribution structures.
We continue to make use of current global distribution structures and conclude our own agreements with our previous Analytik Jena AG distribution partners.
ROBOSCREEN GmbH and Analytik Jena AG will maintain their business links for the future and continue cooperating for the use of their current automation platforms and qPCR instruments.
